FungusCME.org is the official continuing education site of the collaboration of the Mycoses Study Group Education & Research Consortium; the University of Nebraska Medical Center, Center for Continuing Education; and Terranova Medica. The MSG-ERC's mission includes setting the annual educational and research agendas for mycology and providing top-quality continuing education initiatives to MSG-member institutions and to other institutions and practitioners throughout the United States and globally. We thank our generous commercial supporters for their commitment to our live and web-based continuing education efforts. We hope you enjoy the variety of continuing activities present on this site, and we welcome your input on ongoing educational needs in the area of invasive mycoses.
In this interactive, enduring, multimedia activity is based on the third and final component of the ICAAC 2013 satellite symposium, Invasive Mycoses: Consider the Source, Consider the Host. In Invasive Fungal Infections After Solid Organ Transplantation, Barbara D. Alexander, MD, MHS, FIDSA, discusses a case highlighting the management of an invasive mold infection in a patient post lung transplantation. In this activity, Dr Alexander reviews fungal epidemiology based on type of organ transplanted and time from transplantation, explores the performance characteristics of fungal diagnostics specifically in the SOT setting, reviews the guidelines for management of fungal infections in SOT, and discusses genomics and other host defense issues impacting response to therapy. The activity will also include bonus material about current and emerging antifungal therapy and diagnostic options (developed by Peter G. Pappas, MD, FACP).
In this interactive, enduring, multimedia activity is based on the second component of a liveICAAC 2013 satellite symposium, Theoklis Zaoutis, MD, MSCE, discusses cases illustrating the state-of-the-art management of invasive fungal infections (IFIs) in children. Highlighting important issues for the prevention and management of invasive candidiasis and invasive mold infections in oncology and ICU settings, Dr Zaoutis also reviews the levels of evidence behind different diagnostic tests in children, drug dosing strategies, as well as the role of therapeutic dose monitoring. The activity will also include bonus material about current and emerging antifungal therapy and diagnostic options (developed by Peter G. Pappas, MD, FACP).
In this interactive, enduring multimedia activity based on a live ICAAC 2013 Satellite Symposium, Andrew Ullmann, MD, FIDSA, discusses cases illustrating optimal antifungal strategies for at-risk hematopoietic stem cell transplantation (HSCT) patients and for those with documented infections. Join him as he reviews prophylactic strategies as well as first-line and second-line therapy options for aspergillosis and fusariosis. Dr Ullmann also reviews risk -assessment criteria, diagnostic challenges, and host factors affecting outcomes. The activity will also include bonus material about current and emerging antifungal therapy and diagnostic options (developed by Peter Pappas, MD).